No photo of Ellen Mahar Mowry

View Scopus Profile

Ellen Mahar Mowry

Associate Professor

20072020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Ellen Mahar Mowry is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Multiple Sclerosis Medicine & Life Sciences
Vitamin D Medicine & Life Sciences
Pediatrics Medicine & Life Sciences
Recurrence Medicine & Life Sciences
Neuromyelitis Optica Medicine & Life Sciences
Brain Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Demyelinating Diseases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2007 2020

Conducting dietary intervention trials in people with multiple sclerosis: Lessons learned and a path forward

Fitzgerald, K. C., Sand, I. K., Senders, A., Spain, R., Giesser, B., Sullivan, P., Baer, D. J., LaRocca, N., Zackowski, K. & Mowry, E. M., Jan 2020, In : Multiple Sclerosis and Related Disorders. 37, 101478.

Research output: Contribution to journal › Review article

Multiple Sclerosis
Diet
Population

Another sphingosine 1-phosphate receptor modulator for the treatment of patients with multiple sclerosis

Mowry, E. M. & Corboy, J. R., Nov 1 2019, In : The Lancet Neurology. 18, 11, p. 983-985 3 p.

Research output: Contribution to journal › Comment/debate

Lysosphingolipid Receptors
Multiple Sclerosis
Therapeutics

Early complement genes are associated with visual system degeneration in multiple sclerosis

Fitzgerald, K., Kim, K., Smith, M. D., Aston, S. A., Fioravante, N., Rothman, A. M., Krieger, S., Cofield, S. S., Kimbrough, D. J., Bhargava, P., Saidha, S., Whartenby, K., Green, A. J., Mowry, E. M., Cutter, G. R., Lublin, F. D., Baranzini, S. E., De Jager, P. L. & Calabresi, P., Sep 1 2019, In : Brain : a journal of neurology. 142, 9, p. 2722-2736 15 p.

Research output: Contribution to journal › Article

Multiple Sclerosis
Genes
Ganglia
Atrophy
Confidence Intervals

Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosis

Sotirchos, E. S., Gonzalez-Caldito, N., Dewey, B. E., Fitzgerald, K., Glaister, J., Filippatou, A., Ogbuokiri, E., Feldman, S., Kwakyi, O., Risher, H., Crainiceanu, C. M., Pham, D. L., Van Zijl, P. C., Mowry, E. M., Reich, D. S., Prince, J. L., Calabresi, P. & Saidha, S., Jan 1 2019, In : Multiple Sclerosis Journal.

Research output: Contribution to journal › Article

Multiple Sclerosis
Atrophy
Therapeutics
Brain
Gray Matter

Environmental and genetic risk factors for MS: an integrated review

Waubant, E., Lucas, R., Mowry, E. M., Graves, J., Olsson, T., Alfredsson, L. & Langer-Gould, A., Jan 1 2019, (Accepted/In press) In : Annals of Clinical and Translational Neurology.

Research output: Contribution to journal › Review article

Open Access
Multiple Sclerosis
Biological Phenomena
Environmental Exposure
Solar System
Genetic Predisposition to Disease